DK47089A - Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer - Google Patents
Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancerInfo
- Publication number
- DK47089A DK47089A DK047089A DK47089A DK47089A DK 47089 A DK47089 A DK 47089A DK 047089 A DK047089 A DK 047089A DK 47089 A DK47089 A DK 47089A DK 47089 A DK47089 A DK 47089A
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- timal
- tumors
- procedures
- agents
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 2
- 201000011510 cancer Diseases 0.000 title 1
- 230000000254 damaging effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 abstract 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 abstract 2
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 abstract 2
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 abstract 1
- SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 abstract 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 abstract 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000020960 dehydroascorbic acid Nutrition 0.000 abstract 1
- 239000011615 dehydroascorbic acid Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 229940059082 douche Drugs 0.000 abstract 1
- 239000003978 infusion fluid Substances 0.000 abstract 1
- 229940043353 maltol Drugs 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 abstract 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 abstract 1
- 235000012141 vanillin Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT218/88A AT393221B (de) | 1988-02-03 | 1988-02-03 | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK47089D0 DK47089D0 (da) | 1989-02-02 |
| DK47089A true DK47089A (da) | 1989-09-15 |
Family
ID=3484658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK047089A DK47089A (da) | 1988-02-03 | 1989-02-02 | Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5006551A (da) |
| EP (1) | EP0326826B1 (da) |
| JP (1) | JPH01226810A (da) |
| AT (2) | AT393221B (da) |
| DE (1) | DE58901002D1 (da) |
| DK (1) | DK47089A (da) |
| ES (1) | ES2033021T3 (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03165602A (ja) * | 1989-11-24 | 1991-07-17 | Murata Mfg Co Ltd | 誘電体共振器 |
| HU207800B (en) * | 1990-05-10 | 1993-06-28 | Andras Sikter | Process for producing composition for improving condition and for treating different illnesses |
| PL308770A1 (en) * | 1992-11-06 | 1995-08-21 | H E Stanley Pharmaceuticals | Oak bark extract compositions, similar synthetic composition and method of obtaining them |
| US5629327A (en) * | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
| GB9306741D0 (en) * | 1993-03-31 | 1993-05-26 | Biocure Ltd | Compounds |
| US6209259B1 (en) * | 1997-07-11 | 2001-04-03 | Encap, Llc | Seeding treatments |
| IL143488A0 (en) * | 1998-12-07 | 2002-04-21 | Ecosmart Technologies Inc | Cancer treatment composition and method using natural plant essential oils |
| JP2004514650A (ja) * | 2000-05-19 | 2004-05-20 | プロジェニクス・ファーマスーティカルズ・インコーポレイテッド | デヒドロアスコルビン酸処方物およびその使用 |
| AT411730B (de) * | 2002-05-17 | 2004-05-25 | Groke Karl Dr | Mittel zur raucher-entwöhnung oder zur alkohol-entwöhnung |
| SE0201880D0 (sv) * | 2002-06-19 | 2002-06-19 | Milenca Gardovic | Komposition för att behandla hudåkommor och för att förbättra hårtillväxt |
| AT412447B (de) | 2002-11-27 | 2005-03-25 | C Y L Handelsges M B H | Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung |
| US20050124684A1 (en) * | 2003-08-29 | 2005-06-09 | Ying Du | 5-(hydroxymethyl) furfural and derivatives as inhibitors of TNFalpha and IL-1beta production |
| JP5268362B2 (ja) * | 2004-12-17 | 2013-08-21 | アラン ビー． キャッシュ | 寿命を拡大させ、かつ加齢関連疾患の発症を遅らせるための方法 |
| US20110105617A1 (en) * | 2005-01-11 | 2011-05-05 | Sgp & Sons Ab | Method for treatment of neoplastic diseases with alpha-keto glutarate and/or salts thereof |
| PL372183A1 (pl) * | 2005-01-11 | 2006-07-24 | Sgp & Sons Ab | Preparat przeciwnowotworowy oraz zastosowanie preparatu przeciwnowotworowego |
| AT503385B1 (de) * | 2006-03-20 | 2008-05-15 | C Y L Pharmazeutika Gmbh | Mittel zur behandlung von oxidativem stress |
| DE102007007629A1 (de) | 2007-02-16 | 2008-08-21 | Evonik Degussa Gmbh | Verfahren zur Herstellung von 5-Hydroxymethyl-furfural über 5-Acyloxymethyl-furfural als Zwischenprodukt |
| EP2255623A1 (en) * | 2009-05-26 | 2010-12-01 | Volker Wagner-Solbach | Plant nutriments |
| CA2925546C (en) | 2012-10-29 | 2022-06-14 | The University Of North Carolina At Chapel Hill | Methods and compositions for treating mucosal tissue disorders |
| DE102013106530A1 (de) * | 2013-06-21 | 2014-12-24 | Christoph Pallua | Krebsmedikament |
| CA3037235A1 (en) | 2016-09-22 | 2018-03-29 | Alan B. Cash | Method to alleviate the symptoms of pms |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1125675A (en) * | 1966-02-10 | 1968-08-28 | Kyowa Hakko Kogyo Kk | Stable ascorbic acid composition and process for preparing the same |
| JPS52108027A (en) * | 1976-03-09 | 1977-09-10 | Rikagaku Kenkyusho | Anticarcinogen |
| JPS5412312A (en) * | 1977-06-30 | 1979-01-30 | Otsuka Chem Co Ltd | Preparation of ketazine |
| JPS5470428A (en) * | 1977-11-11 | 1979-06-06 | Rikagaku Kenkyusho | Carcinostatic agent |
| JPS54126731A (en) * | 1978-03-20 | 1979-10-02 | Rikagaku Kenkyusho | Carcinostatic agent |
| JPS579712A (en) * | 1980-06-20 | 1982-01-19 | Fukumi Morishige | Instilling (dripping) liquid for intravenous injection |
| ATE11736T1 (de) * | 1980-12-23 | 1985-02-15 | Dr. Franz Koehler Chemie Gmbh | Protektive loesung fuer herz und niere und verfahren zu deren herstellung. |
| WO1983002464A1 (en) * | 1982-01-04 | 1983-07-21 | Seymour, Robert, Stephen | Diameter control in czochralski crystal growth |
| ATE78166T1 (de) * | 1985-10-22 | 1992-08-15 | Silvetti Anthony N | Monosaccharide enthaltende zusammensetzung zum heilen von wunden. |
-
1988
- 1988-02-03 AT AT218/88A patent/AT393221B/de not_active IP Right Cessation
-
1989
- 1989-01-12 AT AT89100493T patent/ATE74006T1/de not_active IP Right Cessation
- 1989-01-12 EP EP89100493A patent/EP0326826B1/de not_active Expired - Lifetime
- 1989-01-12 DE DE8989100493T patent/DE58901002D1/de not_active Expired - Fee Related
- 1989-01-12 ES ES89100493T patent/ES2033021T3/es not_active Expired - Lifetime
- 1989-01-24 US US07/301,035 patent/US5006551A/en not_active Expired - Lifetime
- 1989-02-02 DK DK047089A patent/DK47089A/da not_active Application Discontinuation
- 1989-02-02 JP JP1022747A patent/JPH01226810A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATA21888A (de) | 1991-02-15 |
| JPH01226810A (ja) | 1989-09-11 |
| DK47089D0 (da) | 1989-02-02 |
| AT393221B (de) | 1991-09-10 |
| ATE74006T1 (de) | 1992-04-15 |
| ES2033021T3 (es) | 1996-07-16 |
| EP0326826B1 (de) | 1992-03-25 |
| US5006551A (en) | 1991-04-09 |
| EP0326826A1 (de) | 1989-08-09 |
| DE58901002D1 (de) | 1992-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK47089A (da) | Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer | |
| EA200000759A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
| IS1564B (is) | Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar | |
| DK0502092T3 (da) | Oralt præparat til behandling af inflammatoriske tarmsygdomme | |
| ATE209908T1 (de) | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN | |
| SE8402550D0 (sv) | N-substituerade deriavat av moranolin | |
| JPS5756427A (en) | Medicine containing 2-phenyl-1,2-benzisoselenazole- 3(2h)-one | |
| SE8000435L (sv) | N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning | |
| EA200100127A1 (ru) | Производные фенилксантина | |
| ATE197670T1 (de) | Parenterales busulfan zur behandlung von malignen krankheiten | |
| RU94022017A (ru) | Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды | |
| ATE16191T1 (de) | Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten. | |
| RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
| DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
| SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
| NO162283C (no) | Analogifremgangsmaate til fremstilling av nye terapeutisk,aktive substituerte 3-fenoksy-1-alkoksykarbonyl-alkylamino-propanoler-2. | |
| NO153495C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater. | |
| DK418986D0 (da) | Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf | |
| NO156900B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater. | |
| KR890000108A (ko) | 종양 치료용 약제학적 조성물 | |
| DK225689D0 (da) | Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi | |
| ATE141510T1 (de) | Arzneimittel enthaltend cd14 | |
| ATE126437T1 (de) | Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf. | |
| RU97101420A (ru) | Способ лечения тонзиллита | |
| RU96117923A (ru) | Способ лечения хронических сальпингоофоритов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment | ||
| AHB | Application shelved due to non-payment |